InvestorsObserver
×
News Home

Is Wall Street right about GW Pharmaceuticals PLC- ADR?

Wednesday, April 01, 2020 10:26 AM | InvestorsObserver Analysts

Mentioned in this article

Is Wall Street right about GW Pharmaceuticals PLC- ADR?

Analysts who follow GW Pharmaceuticals PLC- ADR (GWPH) on average expect it to add 111.60% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy.

That average rating earns GW Pharmaceuticals PLC- ADR an Analyst Ranking of 78, which means it ranks higher than 78 of stocks, based on data compiled by InvestorsObserver.

Overall Score - 4.9
Wall Street analysts are rating GWPH a Strong Buy today. Find out what this means to you and get the rest of the rankings on GWPH!

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement.

Investors Observer averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With GW Pharmaceuticals PLC- ADR Stock Today?

GW Pharmaceuticals PLC- ADR (GWPH) stock is higher by 1.68% while the S&P 500 has fallen -2.8% as of 10:20 AM on Wednesday, Apr 1. GWPH has gained $1.47 from the previous closing price of $87.57 on volume of 42,269 shares. Over the past year the S&P 500 is lower by -12.39% while GWPH has fallen -46.24%. GWPH lost -$0.29 per share the over the last 12 months.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App